News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Isotechnika Pharma Inc. (ISA.TO) Reports Second Quarter 2013 Financial Results


8/14/2013 8:42:53 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

EDMONTON, Alberta, Aug. 13, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) (the "Company") has released its financial results for the second quarter ended June 30, 2013.

Recent Developments

On February 5, 2013 the Company announced that it had signed a binding term sheet (the "Term Sheet") with privately held Aurinia Pharmaceuticals Inc. ("Aurinia") for the merger of the two companies, creating a clinical development stage pharmaceutical company focused on the global nephrology market.

Help employers find you! Check out all the jobs and post your resume.


Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES